Annual Update event on the QbD Research Chair for Precision Oncology Research in Glioblastoma
- Home
- News & Events
- Annual Update event on the QbD Research Chair for Precision Oncology Research in Glioblastoma
Annual Update event on the QbD Research Chair for Precision Oncology Research in Glioblastoma
Friday, 21 June 2024
QbD Group
Share
\
\
X (Twitter)
\
\
LinkedIn
\
\
WhatsApp
\
\
Copy link
\
\
Mail
QbD Group held its 3rd annual event for an update on the QbD Chair, hosted at the beautiful Salons Van Edel in Wilrijk.
.jpg?width=1600&height=900&name=QbD%20research%20Chair%202024%20(1).jpg)
QbD Group has been actively supporting our research into glioblastoma ever since Pieter Van Vlierberghe, a close friend of QbD’s CEO Bart Van Acker, was diagnosed with the disease in 2020.
Pieter sadly lost his battle at the end of 2022. However, QbD remains dedicated to supporting the research in his honor and to helping future patients facing this devastating disease.
After an introduction by Bart Van Acker, Mark Peeters, CEO of UZA, presented on the future of healthcare, emphasizing patient-centered care. He discussed how technological advancements will increasingly allow patients to be monitored at home, which will require strong collaboration among multidisciplinary teams, home care providers, and caregivers.
As always, Researcher Yanti De Visser delivered a very accessible presentation on the importance of functional diagnostics. Following her, Professor Frederik De Smet provided an overview of the evolution of the LPCM (Laboratory for Precision Cancer Medicine) and highlighted the positive impact of QbD’s support.
To conclude the event, Hugo Van Puymbroeck, Pieter’s father-in-law, shared the story of his pilgrimage to Compostela. Accompanied by his friend Wim Waes, Hugo embarked on a journey of nearly 1000 kilometers, completed in 43 days. This feat was even more impressive considering Hugo is 75 years old and Wim is 84. Their journey raised an impressive €14,000, which they donated to brain tumor research.
Hugo’s presentation was a touching tribute to his son-in-law, and his story was a testament to the power of dedication and perseverance.
Thank you to everyone who joined us. See you next year!
Previous
.jpg?width=2000&name=QbD%20research%20Chair%202024%20(10).jpg)
.jpg?width=900&height=600&name=QbD%20research%20Chair%202024%20(2).jpg)
.jpg?width=2000&name=QbD%20research%20Chair%202024%20(9).jpg)
.jpg?width=2000&name=QbD%20research%20Chair%202024%20(11).jpg)
.jpg?width=2000&name=QbD%20research%20Chair%202024%20(4).jpg)
.jpg?width=2000&name=QbD%20research%20Chair%202024%20(5).jpg)
.jpg?width=2000&name=QbD%20research%20Chair%202024%20(8).jpg)
.jpg?width=2000&name=QbD%20research%20Chair%202024%20(10).jpg)
.jpg?width=900&height=600&name=QbD%20research%20Chair%202024%20(2).jpg)
.jpg?width=2000&name=QbD%20research%20Chair%202024%20(9).jpg)
.jpg?width=2000&name=QbD%20research%20Chair%202024%20(11).jpg)
.jpg?width=2000&name=QbD%20research%20Chair%202024%20(4).jpg)
.jpg?width=2000&name=QbD%20research%20Chair%202024%20(5).jpg)
.jpg?width=2000&name=QbD%20research%20Chair%202024%20(8).jpg)
.jpg?width=2000&name=QbD%20research%20Chair%202024%20(10).jpg)
.jpg?width=900&height=600&name=QbD%20research%20Chair%202024%20(2).jpg)
.jpg?width=2000&name=QbD%20research%20Chair%202024%20(9).jpg)
Next
More latest news
Previous
30 Mar 2023
QbD Group Foundation: Strengthening Our Commitment to Social Impact
QbD Group has been sponsoring many charities for years. To really embed our social commitment in a...
9 Feb 2022
QbD Wallonia Expands: Welcoming a New Office and a Strengthened Team
QbD Wallonia proudly presents its brand-new office. The Belgian and international reference in...
30 Aug 2023
Belgians Launch Miniature Heart into Space for Groundbreaking Aging Research
Five Belgian companies and research centres - including QbD Group - are joining forces in the...
17 Jan 2024
QbD Chair in Precision Oncology Research for Glioblastoma Renewed for Three More Years
The QbD Chair supports the research of Professor Frederik De Smet on glioblastoma, an aggressive...
27 Nov 2023
Bart Van Acker Establishes Chair to Combat Glioblastoma in Honor of Close Friend’s Battle with Aggressive Brain Tumor
Thanks to the QbD chair, Leuven professor Frederik De Smet is searching for better treatments for...
30 Mar 2023
QbD Group Foundation: Strengthening Our Commitment to Social Impact
QbD Group has been sponsoring many charities for years. To really embed our social commitment in a...
9 Feb 2022
QbD Wallonia Expands: Welcoming a New Office and a Strengthened Team
QbD Wallonia proudly presents its brand-new office. The Belgian and international reference in...
30 Aug 2023
Belgians Launch Miniature Heart into Space for Groundbreaking Aging Research
Five Belgian companies and research centres - including QbD Group - are joining forces in the...
17 Jan 2024
QbD Chair in Precision Oncology Research for Glioblastoma Renewed for Three More Years
The QbD Chair supports the research of Professor Frederik De Smet on glioblastoma, an aggressive...
27 Nov 2023
Bart Van Acker Establishes Chair to Combat Glioblastoma in Honor of Close Friend’s Battle with Aggressive Brain Tumor
Thanks to the QbD chair, Leuven professor Frederik De Smet is searching for better treatments for...
30 Mar 2023
QbD Group Foundation: Strengthening Our Commitment to Social Impact
QbD Group has been sponsoring many charities for years. To really embed our social commitment in a...
9 Feb 2022
QbD Wallonia Expands: Welcoming a New Office and a Strengthened Team
QbD Wallonia proudly presents its brand-new office. The Belgian and international reference in...
Next
- 1
- 2
- 3
Stay ahead in life sciences
Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.
Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.
Twitter Widget Iframe